German China

USA: Biotechnology

Abzena Opts for Sartorius to Equip Integrated CDMO Facilities

| Editor: Alexander Stark

Sartorius headquarters in Göttingen
Gallery: 1 image
Sartorius headquarters in Göttingen (Source: Sartorius)

Abzena has selected Sartorius Stedim to equip its integrated CDMO facilities in Bristol for the development and GMP manufacture of antibody drug conjugates and San Diego for the development and GMP manufacture of monoclonal antibodies and other recombinant proteins.

Göttingen/Germany — The German company will provide both facilities with end-to-end process solutions in single-use (SU) format. It will equip Abzena’s San Diego process development lab with technologies such as Ambr 250, enabling fast scale up to 500 liters initially and later to the 2,000 liters scale single-use bioreactor for its centre of excellence in clinical manufacturing.

In addition to having selected the company's single-use technologies for antibody and ADC production, the Abzena facilities will feature Umetrics process analytics software throughout the process ensuring that all the data captured throughout molecule development is transformed into process knowledge.

Sartorius Stedim Biotech Wins Frost & Sullivan Award

Germany: Biopharmaceuticals

Sartorius Stedim Biotech Wins Frost & Sullivan Award

10/25/2017 - Sartorius Stedim Biotech (SSB) received Frost & Sullivan’s 2017 European Customer Service Leadership Award for Bioanalytical Contract Testing Services. read...

Sartorius Opens Manufacturing Facility for Laboratory Instruments

Germany: Laboratory Equipment

Sartorius Opens Manufacturing Facility for Laboratory Instruments

09/15/2017 - Sartorius officially opened its new production facility as part of Sartorius Campus. The investment has a volume of approx. € 42 million. read...

Comments are being loaded ....

Leave a comment
  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 45080946 / Laborpraxis Worldwide)